1Pollak MN,Schally AV.Mechanisms of antineoplastic action of somatostatin analogs.Proc Soc Exp Biol Med,1998,217:143-152.
2Bauer W, Briner U, Doepfner W, et al.A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci, 1982, 31:1133-1140.
3Plonowski A,Schally AV,Nagy A,et al.Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.Cancer Res,2000,60:2996-3001.
4Cuntz MC,Levine EA,O′Dorisio TM,et al.Intraoperative gamma detection of 125I-lanreotide in women with primary breast cancer.Ann Surg Oncol,1999,6:367-372.
5Gulec SA,Drouant GJ,Fuselier J,et al.Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL.J Surg Res,2001,97:131-137.
6Woltering EA, Barrie R, O′Dorisio TM, et al. Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane.J Surg Res, 1991, 50:245-251.
7Albini A,Florio T,Giunciuglio D,et al.Somatostatin controls Kaposi′s sarcoma tumor growth through inhibition of angiogenesis.FASEB J,1999,13:647-655.
8Danesi R,Agen C,Benelli U,et al.Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).Clin Cancer Res,1997,3:265-272.
9Averbukh E,Halpert M,Yanko R,et al.Octreotide, a somatostatin analogue, fails to inhibit hypoxia-induced retinal neovascularization in the neonatal rat.Int J Exp Diabetes Res,2000,1:39-47.
10Vidal S,Kovacs K,Horvath E,et al.Microvessel density in pituitary adenomas and carcinomas.Virchows Arch,2001,438:595-602.
4Douziech N, Calvo E, Coulombe Z, et al. Inhibitory and stimulatory effects of somatostatin two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP - 1 [ J ]. Endocrinology, 1999, 140 (2) :765.
5Raderer M, Hejna MH, Muller C, et al. Treatment of hepatocellular cancer with the longacting somatostatin analog lanreotide in vitro and in vlvo[ J]. INTJ Onxol, 2000, 16(6) : 1197.
6Sharma K, Sricant CB. Induction of wild-type p53, Bax and acidic cndonucleasc during somatostat in 2 signaled apoptosis in MCF27 human breast cancer cells[J ]. Int J Cancer, 1998, 76 (2) :259.
7Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild - type p.53 [ J ]. Science, 1990, 249:912.
8Lane DP. p53,guardian of the genome[J]. Nature, 1992, 358 : 15.
9Bosari S, Viale G, Bossi P, et al. Cytolasmic accumulation of p53 protein: an independent prognostic indicator of colorectal adenocarcinimas[J]. Cancer Inst, 1994, 84:681.
10Johnson KR, Young KK, Fan W. Antagonistic interplay between antirnitotic and G1 - S arresting agents observed in experimental combination therapy[J]. Clin Cancer Res, 1999, 5: 2559.
